Dorzolamide Hydrochloride

盐酸多佐胺

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameDorzolamide Hydrochloride
Drug Alias NameDorzolamidum多佐胺盐酸杜塞酰胺TrusoptTRUSOPT-PF +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCarbonic anhydrases inhibitors
TargetsCarbonic anhydrases
Therapy Area/IndicationsGlaucoma, Open-AngleOcular Hypertension
Global Approved IndicationsGlaucoma, Open-AngleOcular Hypertension
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited StatesNew Zealand
Original Approved Date1994/12/09
Country/TerritoryUnited StatesNew ZealandGermany
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesMerck & Co Inc
China Registration ClassN/A

Develop Information

Active CompaniesAkornMerck Sharp & Dohme CorpSanten Pharmaceutical Co Ltd
Inactive CompaniesAlfred E. Tiefenbacher (Gmbh & Co Kg)Merck Sharp & Dohme LLC
Active IndicationsGlaucoma, Open-AngleOcular Hypertension
Inactive IndicationsN/A

Other Information

ATC CodeS01EC03
Related LinksWikipediaDrugBankKEGG